注意缺陷/多动障碍中药临床试验设计与评价技术指南

2021-09-06 中华中医药学会儿科分会 药物评价研究

《注意缺陷/多动障碍中药临床试验设计与评价技术指南》为中华中医药学会标准化项目《儿科系列常见病中药临床试验设计与评价技术指南》之一。

中文标题:

注意缺陷/多动障碍中药临床试验设计与评价技术指南

发布日期:

2021-09-06

简要介绍:

《注意缺陷/多动障碍中药临床试验设计与评价技术指南》为中华中医药学会标准化项目《儿科系列常见病中药临床试验设计与评价技术指南》之一。其目的是以临床价值为导向,在病证结合模式下,讨论具有注意缺陷/多动障碍、儿童和中药特点的临床定位、试验设计与实施等相关问题,为中药治疗注意缺陷/多动障碍临床试验设计与评价提供思路和方法。制定过程中先后成立指南工作组、起草专家组和定稿专家组,采用文献研究和共识会议的方法,最终形成指南送审稿定稿。该《指南》的主要内容包括临床定位、试验总体设计、诊断标准与辨证标准、受试者的选择与退出、干预措施、有效性评价、安全性观察、试验流程、试验的质量控制9部分。希望其制定和发布,能为申办者/合同研究组织、研究者在中药治疗注意缺陷/多动障碍的临床试验设计,提供借鉴与参考。 

相关资料下载:
[AttachmentFileName(sort=1, fileName=注意缺陷_多动障碍中药临床试验设计与评价技术指南.pdf)] GetToolGuiderByIdResponse(projectId=1, id=c59c01c002332513, title=注意缺陷/多动障碍中药临床试验设计与评价技术指南, enTitle=, guiderFrom=药物评价研究, authorId=0, author=, summary=《注意缺陷/多动障碍中药临床试验设计与评价技术指南》为中华中医药学会标准化项目《儿科系列常见病中药临床试验设计与评价技术指南》之一。, cover=https://img.medsci.cn/2022122/1642856682212_5579292.png, journalId=0, articlesId=null, associationId=617, associationName=中华中医药学会儿科分会, associationIntro=null, copyright=0, guiderPublishedTime=Mon Sep 06 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<p><span style="color: #333333;">《注意缺陷/多动障碍中药临床试验设计与评价技术指南》为中华中医药学会标准化项目《儿科系列常见病中药临床试验设计与评价技术指南》之一。其目的是以临床价值为导向,在病证结合模式下,讨论具有注意缺陷/多动障碍、儿童和中药特点的临床定位、试验设计与实施等相关问题,为中药治疗注意缺陷/多动障碍临床试验设计与评价提供思路和方法。制定过程中先后成立指南工作组、起草专家组和定稿专家组,采用文献研究和共识会议的方法,最终形成指南送审稿定稿。该《指南》的主要内容包括临床定位、试验总体设计、诊断标准与辨证标准、受试者的选择与退出、干预措施、有效性评价、安全性观察、试验流程、试验的质量控制9部分。希望其制定和发布,能为申办者/合同研究组织、研究者在中药治疗注意缺陷/多动障碍的临床试验设计,提供借鉴与参考。&nbsp;</span></p>, tagList=[TagDto(tagId=6997, tagName=神经心理), TagDto(tagId=9751, tagName=注意缺陷多动障碍), TagDto(tagId=50255, tagName=注意缺陷)], categoryList=[CategoryDto(categoryId=13, categoryName=精神心理, tenant=100), CategoryDto(categoryId=17, categoryName=神经科, tenant=100), CategoryDto(categoryId=18, categoryName=儿科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=0, guiderKeyword=, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=0, guiderRegion=3, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=5661, appHits=46, showAppHits=0, pcHits=239, showPcHits=5613, likes=0, shares=5, comments=3, approvalStatus=1, publishedTime=Sat Jan 22 21:00:28 CST 2022, publishedTimeString=2021-09-06, pcVisible=1, appVisible=1, editorId=0, editor=FUNNYMAN, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=FUNNYMAN, createdTime=Sat Jan 22 21:06:50 CST 2022, updatedBy=5579292, updatedName=FUNNYMAN, updatedTime=Sat Jan 06 06:11:07 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=注意缺陷_多动障碍中药临床试验设计与评价技术指南.pdf)])
注意缺陷_多动障碍中药临床试验设计与评价技术指南.pdf
下载请点击:
评论区 (3)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2099829, encodeId=886d20998296c, content=可以試試啊, beContent=null, objectType=guider, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210420/09716af288084795ba128059da55a818/c3137a18601c4c54bb7d71ac97630870.jpg, createdBy=e9985480565, createdName=ozzy, createdTime=Fri Nov 11 10:37:58 CST 2022, time=2022-11-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1189872, encodeId=b24711898e2df, content=很有参考价值啊, beContent=null, objectType=guider, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=048e6167235, createdName=ms1000001338777518, createdTime=Thu Feb 03 10:53:41 CST 2022, time=2022-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1187743, encodeId=d420118e74316, content=学习学习学习学习我学习我学习学习学习学习学习学习学习学习学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f03a5433387, createdName=ms5000000518166734, createdTime=Mon Jan 24 17:17:02 CST 2022, time=2022-01-24, status=1, ipAttribution=)]
    2022-11-11 ozzy

    可以試試啊

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2099829, encodeId=886d20998296c, content=可以試試啊, beContent=null, objectType=guider, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210420/09716af288084795ba128059da55a818/c3137a18601c4c54bb7d71ac97630870.jpg, createdBy=e9985480565, createdName=ozzy, createdTime=Fri Nov 11 10:37:58 CST 2022, time=2022-11-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1189872, encodeId=b24711898e2df, content=很有参考价值啊, beContent=null, objectType=guider, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=048e6167235, createdName=ms1000001338777518, createdTime=Thu Feb 03 10:53:41 CST 2022, time=2022-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1187743, encodeId=d420118e74316, content=学习学习学习学习我学习我学习学习学习学习学习学习学习学习学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f03a5433387, createdName=ms5000000518166734, createdTime=Mon Jan 24 17:17:02 CST 2022, time=2022-01-24, status=1, ipAttribution=)]
    2022-02-03 ms1000001338777518

    很有参考价值啊

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=2099829, encodeId=886d20998296c, content=可以試試啊, beContent=null, objectType=guider, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210420/09716af288084795ba128059da55a818/c3137a18601c4c54bb7d71ac97630870.jpg, createdBy=e9985480565, createdName=ozzy, createdTime=Fri Nov 11 10:37:58 CST 2022, time=2022-11-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1189872, encodeId=b24711898e2df, content=很有参考价值啊, beContent=null, objectType=guider, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=048e6167235, createdName=ms1000001338777518, createdTime=Thu Feb 03 10:53:41 CST 2022, time=2022-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1187743, encodeId=d420118e74316, content=学习学习学习学习我学习我学习学习学习学习学习学习学习学习学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f03a5433387, createdName=ms5000000518166734, createdTime=Mon Jan 24 17:17:02 CST 2022, time=2022-01-24, status=1, ipAttribution=)]
    2022-01-24 ms5000000518166734

    学习学习学习学习我学习我学习学习学习学习学习学习学习学习学习学习

    0